Key features and details
- Glucocorticoid receptor binding affinity. Highly potent IL-4 and IL-5 release inhibitor.
- CAS Number: 51333-22-3
- Purity: > 98%
- Soluble in DMSO to 100 mM and in ethanol to 50 mM
- Form / State: Solid
- Source: Synthetic
Product nameBudesonide, Glucocorticoid receptor binding affinity. Highly IL-4 and IL-5 release inhibitor.
DescriptionGlucocorticoid receptor binding affinity. Highly potent IL-4 and IL-5 release inhibitor.
Glucocorticoid receptor binding affinity, stimulates transcription of target gene. Highly potent IL-4 and IL-5 release inhibitor (IC50 values are 320 and 220 pM, respectively). Potent concanavalin A-induced proliferation inhibitor (IC50 = 1.3 nM). Anti-asthmatic and anti-inflammatory agent. Orally active. Active in vivo and in vitro.
Storage instructionsStore at Room Temperature. Store under desiccating conditions. The product can be stored for up to 12 months.
Solubility overviewSoluble in DMSO to 100 mM and in ethanol to 50 mM
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
- Signal Transduction
- Signaling Pathway
- Nuclear Signaling
- Nuclear Hormone Receptors
- Retinoic & Retinoid
- Epigenetics and Nuclear Signaling
- Nuclear Signaling Pathways
- Nuclear Receptors
- Orphan Nuclear Receptors
- Pathways and Processes
- Metabolic signaling pathways
- Nucleotide metabolism
- Molecular processes
- Mitochondrial transcription
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab141279 has not yet been referenced specifically in any publications.